Quarter
Charts

ImmunityBio, Inc.

IBRX

CIK 0001326110 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$38M
↑+407.0% +$31Mvs FY2024 (Q4)
Operating Income
$34M
Net Income
$19M
Gross Profit
$38M
↑+401.9% +$30Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Strong
67/100
  • Profitability
    100ROIC 40.9% (10% = solid, 20%+ = moat)
  • Liquidity
    100Current Ratio 5.10 (above 1.5 = solid)
  • Leverage
    0Insufficient data
  • Efficiency
    4Asset Turnover 0.26x (1.0+ = capital-efficient)
  • Growth
    100Revenue YoY +407.0% (10% = solid, 25%+ = elite)
  • Margin Trend
    100Op Margin -173.5% · trend +82652.8pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$4M
investment in PP&E
Stock buybacks (TTM)
—
share count reduction
Stock-based comp (TTM)
$37M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$502M
everything owned
Total liabilities
$1.00B
everything owed
Stockholders' equity
$-500M
shareholder claim

Recent performance · 49 quarters

Revenue↑+407.0% +$31M
$38M
Net Income↑+21.6% +$18M
$-67M
Free Cash Flow↑+57.2% +$1M
$-903K
Operating Margin↑+1140.8pts
-173.5%

Drill down

IBRX Sankey

See ImmunityBio, Inc.'s revenue flow into every line item of the income statement and balance sheet — every dollar accounted for, with prior-period comparison.

Open Sankey

IBRX Charts

49 quarters of historical line items — Income, Cash Flow, Balance Sheet, plus margins. Click any chart for the trend dialog.

Open Charts

IBRX Key Metrics

EPS, BVPS, FCF/Share, ROE, ROA, ROIC, D/E, Current Ratio, Quick Ratio, Asset Turnover — 10 CFA-grade fundamentals derived from EDGAR data.

Open Key Metrics